The possibility to directly harness aberrant metabolism represents a new strategy to improve the selectivity of PDT agents. Photosensitizers that are able to enter target cells via endogenous metabolic transporters, especially those that are expressed differentially between target cells and their surrounding tissue, would increase selective cell ablation and minimize potential side effects.